Clinical trial improves treatment of genetic rickets

A new study shows a drug developed in conjunction with investigators at Indiana University School of Medicine to alleviate symptoms of a rare musculoskeletal condition is significantly more effective than conventional therapies. The findings are published in Lancet. X-linked hypophosphatemia, or XLH, is a phosphate-wasting disease that causes rickets and…